This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders Europe
17 - 19 March 2026
Austria CenterAustria Center, Vienna
Book Now
Menu
Book
keyboard_arrow_right

Main Conference – Day 2 - CET (Central European Time, GMT+01:00)

keyboard_arrow_leftSearch & Filter
search
Main Conference – Day 2 - CET (Central European Time, GMT+01:00)
search
Showing 1 of 1 Streams
08:00 - 08:10
WiRNA Breakfast
08:10 - 09:00
WiRNA Panel: Innovators in RNA - Women Pioneering Biotech Success

Our distinguished panelists will share their journeys of building successful biotech ventures, overcoming industry challenges, and translating cutting-edge RNA science into life-changing treatments. Discover the latest developments in RNA therapeutics, learn about emerging opportunities in this rapidly evolving field, and gain insights into what it takes to lead innovation in one of biotech's most promising sectors.

  • Paola Pozzi - Partner, Sofinnova Telethon Fund, Sofinnova Partners
  • Michelle Lynn Hall - General Partner, Entrée Capital
  • Renee Williams - CBO, Signify Bio
  • Karina Thorn - Vice President, Head of Nucleic Acid Research, Novo Nordisk
  • Sophia Lugo - CEO, Radar Therapeutics
  • Elisa Elisa Kulterer - Researcher, University of Vienna
09:00 - 10:00
Round Tables: The RNA Lifecycle
Table 1: AI Adoption for Discovery and Target Selection
Table 5: Extrahepatic Delivery of RNA Cargos
Table 2: RNA Synthesis Strategies & Design
Table 6: Clinical Biomarker Strategies for RNA Therapeutics: Non-invasive Approaches to Therapeutic Readouts
Table 3: Immunogenicity of OligonucleotidesTable 7: Overlooked Opportunities in RNA Medicines
Table 4: Preclinical Challenges in RNA Research: Bridging Translational Gaps with Human-Relevant and Non-Animal ModelsTable 8: Scaling RNA Therapeutics: Overcoming Manufacturing Challenges for Clinical and Commercial Success
  • Peter Weinstein - Chief Executive Officer, Circurna
  • Marie Wikstrom-Lindholm - CSO, Silence Therapeutics
  • Sudhir Agrawal - President and Founder, Arnay Sciences
  • Bogdan Rivoal - CEO, NeXendia
  • Arun Kumar - RNA Innovations Programs Leader, CEPI
  • Steffen Schubert - Vice President- Drug Discovery, Silence Therapeutics
  • Cesar Lopez-Camacho - Group Leader, University Of Oxford
  • Miroslav Gaparek - CEO, Sensible Biotechnologies
  • Sonja Merkas, PhD - Founder, Creator and Doer, Livinovea
Main Conference – Day 1
Filter
Streams
Clear
Formats
Choose Day